This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
ASP 株式概要
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men’s and women’s health.
Acerus Pharmaceuticals Corporation 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | CA$0.36 |
| 52週高値 | CA$10.00 |
| 52週安値 | CA$0.28 |
| ベータ | 0.99 |
| 11ヶ月の変化 | 0% |
| 3ヶ月変化 | n/a |
| 1年変化 | -96.00% |
| 33年間の変化 | -96.40% |
| 5年間の変化 | -99.29% |
| IPOからの変化 | -99.92% |
最新ニュース
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
株主還元
| ASP | CA Pharmaceuticals | CA 市場 | |
|---|---|---|---|
| 7D | 0% | -8.8% | 1.2% |
| 1Y | -96.0% | 25.1% | 11.8% |
業界別リターン: ASP underperformed the Canadian Pharmaceuticals industry which returned -55.7% over the past year.
リターン対市場: ASP underperformed the Canadian Market which returned -5.2% over the past year.
価格変動
| ASP volatility | |
|---|---|
| ASP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 12.8% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.8% |
| 10% least volatile stocks in CA Market | 3.0% |
安定した株価: ASP's share price has been volatile over the past 3 months.
時間の経過による変動: Insufficient data to determine ASP's volatility change over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2008 | 14 | Ed Gudaitis | www.aceruspharma.com |
Acerus Pharmaceuticals Corporation 基礎のまとめ
| ASP 基礎統計学 | |
|---|---|
| 時価総額 | CA$2.77m |
| 収益（TTM） | -CA$38.24m |
| 売上高(TTM) | CA$4.14m |
0.7x
P/Sレシオ-0.1x
PER（株価収益率ASP は割高か？
公正価値と評価分析を参照収益と収入
| ASP 損益計算書（TTM） | |
|---|---|
| 収益 | US$3.04m |
| 売上原価 | US$1.33m |
| 売上総利益 | US$1.71m |
| その他の費用 | US$29.79m |
| 収益 | -US$28.08m |
直近の収益報告
Sep 30, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -3.64 |
| グロス・マージン | 56.32% |
| 純利益率 | -924.33% |
| 有利子負債／自己資本比率 | -329.8% |
ASP の長期的なパフォーマンスは？
過去の実績と比較を見る